129 related articles for article (PubMed ID: 34097964)
1. Nanoparticles based on polymers modified with pH-sensitive molecular switch and low molecular weight heparin carrying Celastrol and ferrocene for breast cancer treatment.
Qian Y; Zhang J; Xu R; Li Q; Shen Q; Zhu G
Int J Biol Macromol; 2021 Jul; 183():2215-2226. PubMed ID: 34097964
[TBL] [Abstract][Full Text] [Related]
2. Coadministration of chemotherapy and PI3K/Akt pathway treatment with multistage acidity/CathB enzyme-responsive nanocarriers for inhibiting the metastasis of breast cancer.
Zuo T; Li J; Zhang J; Sun L; Liang X; Yang J; Shen Q
Biomater Sci; 2019 Dec; 7(12):5054-5067. PubMed ID: 31552922
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J
Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and evaluation of in vitro cytotoxicity and in vivo antitumor activity of asiatic acid-loaded poly lactic-co-glycolic acid nanoparticles: A strategy of treating breast cancer.
Dutta S; Chakraborty P; Basak S; Ghosh S; Ghosh N; Chatterjee S; Dewanjee S; Sil PC
Life Sci; 2022 Oct; 307():120876. PubMed ID: 35961595
[TBL] [Abstract][Full Text] [Related]
5. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
[TBL] [Abstract][Full Text] [Related]
6. Fenton-reaction-stimulative nanoparticles decorated with a reactive-oxygen-species (ROS)-responsive molecular switch for ROS amplification and triple negative breast cancer therapy.
Zhang J; Zuo T; Liang X; Xu Y; Yang Y; Fang T; Li J; Chen D; Shen Q
J Mater Chem B; 2019 Dec; 7(45):7141-7151. PubMed ID: 31663577
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment.
Xu Y; Liu D; Hu J; Ding P; Chen M
Int J Pharm; 2020 Jan; 573():118637. PubMed ID: 31550511
[TBL] [Abstract][Full Text] [Related]
8. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
9. A chitosan/mesoporous silica nanoparticle-based anticancer drug delivery system with a "tumor-triggered targeting" property.
Liao T; Liu C; Ren J; Chen H; Kuang Y; Jiang B; Chen J; Sun Z; Li C
Int J Biol Macromol; 2021 Jul; 183():2017-2029. PubMed ID: 34097958
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
Wang S; Zhang J; Wang Y; Chen M
Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.
Palma G; Conte C; Barbieri A; Bimonte S; Luciano A; Rea D; Ungaro F; Tirino P; Quaglia F; Arra C
Int J Pharm; 2014 Oct; 473(1-2):55-63. PubMed ID: 24992317
[TBL] [Abstract][Full Text] [Related]
12. Polyethylenimine (PEI)-modified poly (lactic-co-glycolic) acid (PLGA) nanoparticles conjugated with tumor-homing bacteria facilitate high intensity focused ultrasound-mediated tumor ablation.
Wang D; Jiang F; Wang L; Tang Y; Zhang Z; Du Y; Zou J
Biochem Biophys Res Commun; 2021 Sep; 571():104-109. PubMed ID: 34314995
[TBL] [Abstract][Full Text] [Related]
13. Artesunate-loaded poly (lactic-co-glycolic acid)/polydopamine-manganese oxides nanoparticles as an oxidase mimic for tumor chemo-catalytic therapy.
Xi J; Huang Y; Chen J; Zhang J; Gao L; Fan L; Qian X
Int J Biol Macromol; 2021 Jun; 181():72-81. PubMed ID: 33771546
[TBL] [Abstract][Full Text] [Related]
14. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
16. Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery.
Wang H; Wu J; Williams GR; Fan Q; Niu S; Wu J; Xie X; Zhu LM
J Nanobiotechnology; 2019 May; 17(1):60. PubMed ID: 31084622
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent magnetic PEI-PLGA nanoparticles loaded with paclitaxel for concurrent cell imaging, enhanced apoptosis and autophagy in human brain cancer.
Wang X; Yang L; Zhang H; Tian B; Li R; Hou X; Wei F
Colloids Surf B Biointerfaces; 2018 Dec; 172():708-717. PubMed ID: 30245296
[TBL] [Abstract][Full Text] [Related]
18. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.
Yang T; Nyiawung D; Silber A; Hao J; Lai L; Bai S
AAPS PharmSciTech; 2012 Dec; 13(4):1309-18. PubMed ID: 23054983
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.
Chen H; Gao J; Lu Y; Kou G; Zhang H; Fan L; Sun Z; Guo Y; Zhong Y
J Control Release; 2008 Jun; 128(3):209-16. PubMed ID: 18450313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
